SC 13D/A

REXAHN PHARMACEUTICALS, INC SC 13DA 7-20-2012 (AHN)

Company: Opus Genetics, Inc.
Filed: July 20, 2012
Accession Number: 0001140361-12-033571

View Document ↗ View on SEC.gov ↗